World Library  
Flag as Inappropriate
Email this Article

Single-photon emission computed tomography

Article Id: WHEBN0000291499
Reproduction Date:

Title: Single-photon emission computed tomography  
Author: World Heritage Encyclopedia
Language: English
Subject: Positron emission tomography, Medical imaging, Emission computed tomography, CT scan, Neuroimaging
Collection: 3D Nuclear Medical Imaging, Articles Containing Video Clips, Medical Physics, Neuroimaging, Radiobiology
Publisher: World Heritage Encyclopedia

Single-photon emission computed tomography

Single-photon emission computed tomography.
A SPECT slice of the distribution of technetium exametazime within a patient's brain.
ICD-9-CM 92.0-92.1
OPS-301 code 3-72
Animation of a SPECT scanning procedure.

Single-photon emission computed tomography (SPECT, or less commonly, SPET) is a nuclear medicine tomographic imaging technique using gamma rays.[1] It is very similar to conventional nuclear medicine planar imaging using a gamma camera.[2] However, it is able to provide true 3D information. This information is typically presented as cross-sectional slices through the patient, but can be freely reformatted or manipulated as required.

The technique requires delivery of a gamma-emitting radioisotope (a radionuclide) into the patient, normally through injection into the bloodstream. On occasion, the radioisotope is a simple soluble dissolved ion, such as a radioisotope of gallium(III). Most of the time, though, a marker radioisotope is attached to a specific ligand to create a radioligand, whose properties bind it to certain types of tissues. This marriage allows the combination of ligand and radiopharmaceutical to be carried and bound to a place of interest in the body, where the ligand concentration is seen by a gamma camera.


  • Principles 1
  • Application 2
    • Myocardial perfusion imaging 2.1
    • Functional brain imaging 2.2
  • Reconstruction 3
  • Typical SPECT acquisition protocols 4
  • SPECT/CT 5
  • Use in court 6
  • See also 7
  • References 8
  • Further reading 9
  • External links 10


A Siemens brand SPECT scanner, consisting of two gamma cameras.

Instead of just "taking a picture" of anatomical structures, a SPECT scan monitors level of biological activity at each place in the 3-D region analyzed. Emissions from the radionuclide indicate amounts of blood flow in the capillaries of the imaged regions. In the same way that a plain X-ray is a 2-dimensional (2-D) view of a 3-dimensional structure, the image obtained by a gamma camera is a 2-D view of 3-D distribution of a radionuclide.

SPECT imaging is performed by using a gamma camera to acquire multiple 2-D images (also called projections), from multiple angles. A computer is then used to apply a tomographic reconstruction algorithm to the multiple projections, yielding a 3-D data set. This data set may then be manipulated to show thin slices along any chosen axis of the body, similar to those obtained from other tomographic techniques, such as magnetic resonance imaging (MRI), X-ray computed tomography (X-ray CT), and positron emission tomography (PET).

SPECT is similar to PET in its use of radioactive tracer material and detection of gamma rays. In contrast with PET, however, the tracers used in SPECT emit gamma radiation that is measured directly, whereas PET tracers emit positrons that annihilate with electrons up to a few millimeters away, causing two gamma photons to be emitted in opposite directions. A PET scanner detects these emissions "coincident" in time, which provides more radiation event localization information and, thus, higher spatial resolution images than SPECT (which has about 1 cm resolution). SPECT scans, however, are significantly less expensive than PET scans, in part because they are able to use longer-lived more easily obtained radioisotopes than PET.

Because SPECT acquisition is very similar to planar gamma camera imaging, the same radiopharmaceuticals may be used. If a patient is examined in another type of nuclear medicine scan, but the images are non-diagnostic, it may be possible to proceed straight to SPECT by moving the patient to a SPECT instrument, or even by simply reconfiguring the camera for SPECT image acquisition while the patient remains on the table.

SPECT machine performing a total body bone scan. The patient lies on a table that slides through the machine, while a pair of gamma cameras rotate around her.

To acquire SPECT images, the gamma camera is rotated around the patient. Projections are acquired at defined points during the rotation, typically every 3–6 degrees. In most cases, a full 360-degree rotation is used to obtain an optimal reconstruction. The time taken to obtain each projection is also variable, but 15–20 seconds is typical. This gives a total scan time of 15–20 minutes.

Multi-headed gamma cameras can provide accelerated acquisition. For example, a dual-headed camera can be used with heads spaced 180 degrees apart, allowing two projections to be acquired simultaneously, with each head requiring 180 degrees of rotation. Triple-head cameras with 120-degree spacing are also used.

Cardiac gated acquisitions are possible with SPECT, just as with planar imaging techniques such as Multi Gated Acquisition Scan (MUGA). Triggered by electrocardiogram (EKG) to obtain differential information about the heart in various parts of its cycle, gated myocardial SPECT can be used to obtain quantitative information about myocardial perfusion, thickness, and contractility of the myocardium during various parts of the cardiac cycle, and also to allow calculation of left ventricular ejection fraction, stroke volume, and cardiac output.


SPECT can be used to complement any gamma imaging study, where a true 3D representation can be helpful, e.g., tumor imaging, infection (leukocyte) imaging, thyroid imaging or bone scintigraphy.

Because SPECT permits accurate localisation in 3D space, it can be used to provide information about localised function in internal organs, such as functional cardiac or brain imaging.

Myocardial perfusion imaging

Myocardial perfusion imaging (MPI) is a form of functional cardiac imaging, used for the diagnosis of ischemic heart disease. The underlying principle is that under conditions of stress, diseased myocardium receives less blood flow than normal myocardium. MPI is one of several types of cardiac stress test.

A cardiac specific radiopharmaceutical is administered, e.g., 99mTc-tetrofosmin (Myoview, GE healthcare), 99mTc-sestamibi (Cardiolite, Bristol-Myers Squibb). Following this, the heart rate is raised to induce myocardial stress, either by exercise or pharmacologically with adenosine, dobutamine, or dipyridamole (aminophylline can be used to reverse the effects of dipyridamole).

SPECT imaging performed after stress reveals the distribution of the radiopharmaceutical, and therefore the relative blood flow to the different regions of the myocardium. Diagnosis is made by comparing stress images to a further set of images obtained at rest. As the radionuclide redistributes slowly, it is not usually possible to perform both sets of images on the same day, hence a second attendance is required 1–7 days later (although, with a Tl-201 myocardial perfusion study with dipyridamole, rest images can be acquired as little as two hours post-stress). However, if stress imaging is normal, it is unnecessary to perform rest imaging, as it too will be normal; thus, stress imaging is normally performed first.

MPI has been demonstrated to have an overall accuracy of about 83% (sensitivity: 85%; specificity: 72%),[3] and is comparable with (or better than) other non-invasive tests for ischemic heart disease.

Functional brain imaging

Usually, the gamma-emitting tracer used in functional brain imaging is 99mTc-HMPAO (hexamethylpropylene amine oxime). 99mTc is a metastable nuclear isomer that emits gamma rays that can be detected by a gamma camera. Attaching it to HMPAO allows 99mTc to be taken up by brain tissue in a manner proportional to brain blood flow, in turn allowing cerebral blood flow to be assessed with the nuclear gamma camera.

Because blood flow in the brain is tightly coupled to local brain metabolism and energy use, the 99mTc-HMPAO tracer (as well as the similar 99mTc-EC tracer) is used to assess brain metabolism regionally, in an attempt to diagnose and differentiate the different causal pathologies of dementia. Meta-analysis of many reported studies suggests that SPECT with this tracer is about 74% sensitive at diagnosing Alzheimer's disease vs. 81% sensitivity for clinical exam (cognitive testing, etc.). More recent studies have shown the accuracy of SPECT in Alzheimer's diagnosis may be as high as 88%.[4] In meta analysis, SPECT was superior to clinical exam and clinical criteria (91% vs. 70%) in being able to differentiate Alzheimer's disease from vascular dementias.[5] This latter ability relates to SPECT's imaging of local metabolism of the brain, in which the patchy loss of cortical metabolism seen in multiple strokes differs clearly from the more even or "smooth" loss of non-occipital cortical brain function typical of Alzheimer's disease. Another recent review article showed that multi-headed SPECT cameras with quantitative analysis result in an overall sensitivity of 84-89% and an overall specificity of 83-89% in cross sectional studies and sensitivity of 82-96% and specificity of 83-89% for longitudinal studies of dementia [6]

99mTc-HMPAO SPECT scanning competes with fludeoxyglucose (FDG) PET scanning of the brain, which works to assess regional brain glucose metabolism, to provide very similar information about local brain damage from many processes. SPECT is more widely available, because the radioisotope used is longer-lasting and far less expensive in SPECT, and the gamma scanning equipment is less expensive as well. While 99mTc is extracted from relatively simple technetium-99m generators, which are delivered to hospitals and scanning centers weekly to supply fresh radioisotope, FDG PET relies on FDG, which is made in an expensive medical cyclotron and "hot-lab" (automated chemistry lab for radiopharmaceutical manufacture), and then delivered immediately to scanning sites because of the natural short 110-minute half-life of Fluorine-18.


Reconstructed images typically have resolutions of 64×64 or 128×128 pixels, with the pixel sizes ranging from 3–6 mm. The number of projections acquired is chosen to be approximately equal to the width of the resulting images. In general, the resulting reconstructed images will be of lower resolution, have increased noise than planar images, and be susceptible to artifacts.

Scanning is time consuming, and it is essential that there is no patient movement during the scan time. Movement can cause significant degradation of the reconstructed images, although movement compensation reconstruction techniques can help with this. A highly uneven distribution of radiopharmaceutical also has the potential to cause artifacts. A very intense area of activity (e.g., the bladder) can cause extensive streaking of the images and obscure neighboring areas of activity. (This is a limitation of the filtered back projection reconstruction algorithm. Iterative reconstruction is an alternative algorithm that is growing in importance, as it is less sensitive to artifacts and can also correct for attenuation and depth dependent blurring).

Attenuation of the gamma rays within the patient can lead to significant underestimation of activity in deep tissues, compared to superficial tissues. Approximate correction is possible, based on relative position of the activity. However, optimal correction is obtained with measured attenuation values. Modern SPECT equipment is available with an integrated X-ray CT scanner. As X-ray CT images are an attenuation map of the tissues, this data can be incorporated into the SPECT reconstruction to correct for attenuation. It also provides a precisely registered CT image, which can provide additional anatomical information.

Typical SPECT acquisition protocols

Study Radioisotope Emission energy (keV) Half-life Radiopharmaceutical Activity (MBq) Rotation (degrees) Projections Image resolution Time per projection (s)
Bone scan technetium-99m 140 6 hours Phosphonates / Bisphosphonates 800 360 120 128 x 128 30
Myocardial perfusion scan technetium-99m 140 6 hours tetrofosmin; Sestamibi 700 180 60 64 x 64 25
Sestamibi parathyroid scan technetium-99m 140 6 hours Sestamibi
Brain scan technetium-99m 140 6 hours HMPAO; ECD 555-1110 360 64 128 x 128 30
Neuroendocrine or neurological tumor scan iodine-123 or iodine-131 159 13 hours or 8 days MIBG 400 360 60 64 x 64 30
White cell scan indium-111 & technetium-99m 171 & 245 67 hours in vitro labelled leucocytes 18 360 60 64 x 64 30


In some cases a SPECT gamma scanner may be built to operate with a conventional CT scanner, with coregistration of images. As in PET/CT, this allows location of tumors or tissues which may be seen on SPECT scintigraphy, but are difficult to locate precisely with regard to other anatomical structures. Such scans are most useful for tissues outside the brain, where location of tissues may be far more variable. For example, SPECT/CT may be used in sestamibi parathyroid scan applications, where the technique is useful in locating ectopic parathyroid adenomas which may not be in their usual locations in the thyroid gland.[7]

Use in court

In 2013 SPECT was used in a Belgian courtroom in an attempt to assess whether or not Kim de Gelder was accountable for his actions. Kim de Gelder was on trial for the murder of two infants and one nanny in 2009, which is known as the Dendermonde nursery attack. The defense argued that de Gelder was suffering from schizoid psychosis, which in their opinion could be inferred from a SPECT scan of his brain. There was a sizable public debate over whether neuroimaging techniques of this kind have a place in the courtroom. On March 22, 2013 Kim de Gelder was found guilty of four counts of murder and was sentenced to life imprisonment.

See also


  1. ^ SPECT at the US National Library of Medicine Medical Subject Headings (MeSH)
  2. ^ "A CdTe detector for hyperspectral SPECT imaging". IOP Journal of Instrumentation. 
  3. ^ Elhendy, A; Bax, JJ; Poldermans, D (2002). "Dobutamine stress myocardial perfusion imaging in coronary artery disease.". Journal of Nuclear Medicine 43 (12): 1634–46.  
  4. ^ Bonte FJ, Harris TS, Hynan LS, Bigio EH, White CL (2006). "Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation". Clin Nucl Med 31 (7): 376–8.  
  5. ^ Dougall NJ, Bruggink S, Ebmeier KP (2004). "Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia". Am J Geriatr Psychiatry 12 (6): 554–70.  
  6. ^ Henderson, Theodore (December 2012). "The diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging". CNS Spectrums 17 (4): 188–89.  
  7. ^ [2] PET/CT sestamibi vs. other modalities for parathyroid imaging.

Further reading

  • Bruyant, P.P. "Analytic and iterative reconstruction algorithms in SPECT" Journal Of Nuclear Medicine 43(10):1343-1358, 2002
  • .  
  • , Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease, J Nucl Med 2002 43: 1634–1646et al.Elhendy
  • A review on brain-imaging applications of SPECT: W. Gordon Frankle, Mark Slifstein, Peter S. Talbot, and Marc Laruelle (2005). "Neuroreceptor Imaging in Psychiatry: Theory and Applications". International Review of Neurobiology, 67: 385–440. doi:10.1016/S0074-7742(05)67011-0
  • Practical SPECT/CT In Nuclear Medicine - Jones / Hogg / Seeram - Release Date: 31 Mar 2013 ISBN 978-1447147022 Edition: 2013
  • Willowson K, Bailey DL, Baldock C, 2008. Quantitative SPECT reconstruction using CT-derived corrections. Phys. Med. Biol. 53 3099-3112.

External links

  • Human Health Campus, The official website of the International Atomic Energy Agency dedicated to Professionals in Radiation Medicine. This site is managed by the Division of Human Health, Department of Nuclear Sciences and Applications
  • National Isotope Development Center Reference information on radioisotopes including those for SPECT; coordination and management of isotope production, availability, and distribution
  • Isotope Development & Production for Research and Applications (IDPRA) U.S. Department of Energy program for isotope production and production research and development
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Hawaii eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.